Investors Hub Daily
iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Hot on StockWiki
My Image Gallery
Market Trends and Strategies
$heff's $tation of $tocks & $olid DD
'RPTP' - (Research and Markets: Raptor Pharmaceuticals Corp.
Post New Msg
Monday, October 08, 2012 8:43:58 AM
'RPTP' - (Research and Markets: Raptor Pharmaceuticals Corp. - Product Pipeline Review - 2012)
DUBLIN, Oct 08, 2012 (BUSINESS WIRE) -- Research and Markets
) has announced the
addition of Global Markets Direct's new company profile "Raptor Pharmaceuticals
Corp. - Product Pipeline Review - 2012" to their offering.
This report provides data on the Raptor Pharmaceuticals Corp.'s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
- Raptor Pharmaceuticals Corp. - Brief Raptor Pharmaceuticals Corp. overview
including business description, key information and facts, and its locations and
- Review of current pipeline of Raptor Pharmaceuticals Corp. human therapeutic
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Raptor
Pharmaceuticals Corp. with complete description of the product's developmental
history, mechanis m of action, therapeutic class, target and major milestones.
- Recent updates of the Raptor Pharmaceuticals Corp.'s pipeline in the last
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to Buy:
- Evaluate Raptor Pharmaceuticals Corp.'s strategic position with total access
to detailed information on its product pipeline.
- Assess the growth potential of Raptor Pharmaceuticals Corp. in its therapy
areas of focus.
- Identify new drug targets and therapeutic classes in the Raptor
Pharmaceuticals Corp.'s R&D portfolio and develop key strategic initiatives to
reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to
fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Raptor
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Raptor Pharmaceuticals Corp.
and identify potential opportunities in those areas.
For more information visit
Source: Global Markets Direct
SOURCE: Research and Markets
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Copyright Business Wire 2012
INDUSTRY KEYWORD: Health
Source: Comtext Market News
Post New Msg
Report TOS Violation
+/- to Watchlist
© 2013 InvestorsHub.Com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App